US clinical-stage biotech Keros Therapeutics has announced a strategic realignment designed to reallocate resources towards ...

Danish biotech Genmab (Nasdaq: GMAB) posted second-quarter revenue of $925 million, up 19% from a year earlier, driven by higher royalties from Johnson & Johnson’s (NYSE: JNJ) Darzalex (daratumumab) ...

Drug-resistant infections now claim more lives each year than HIV/AIDS or malaria, and the toll is rising. The World Health Organization warns that without urgent action, antimicrobial resistance (AMR ...

Danish biotech Genmab (Nasdaq: GMAB) and US partner AbbVie (NYSE: ABBV) have reported a decisive win in a Phase III study of ...

The National Institute for Health and Care Excellence (NICE) has issued final guidance recommending Chiesi’s idebenone within ...

China-based Everest Medicines (HKEX: 1952) has secured full regulatory approval for Nefecon (budesonide) in Taiwan, marking the last of its Asian territories to grant the go-ahead for the ...

USA-based biotech DoveTree Medicines has signed a far-reaching partnership with Chinese drug discovery company XtalPi (HKEX: 2228), in a deal worth up to $5.99 billion.

US pharma major Eli Lilly’s shares plunged more than 14% to $630.61 after it announced what was seen by the market ...

Germany’s Merck KGaA (MRK: DE) has reported second quarter earnings that missed analyst expectations. The life sciences company’s earnings before interest, taxes, depreciation and amortization (EBITDA ...

Eli Lilly (NYSE: LLY) posted a 38% jump in revenue to $15.6 billion in the second quarter of 2025, driven by surging demand ...

US artificial intelligence drug discovery firm Chai Discovery has secured $70 million in Series A funding, drawing backing ...

Shares of US clinical-stage company Eledon Pharmaceuticals shot up 9.9% to close at $3.44 yesterday, after it announced ...